140 related articles for article (PubMed ID: 18630272)
1. [Insulino-mimetic effects of bis (alpha-furancarboxylato) oxovanadium (IV) in vitro].
Li YR; Gao LH; Ma YL; Niu YF; Liu WP; Li L
Yao Xue Xue Bao; 2008 Mar; 43(3):318-22. PubMed ID: 18630272
[TBL] [Abstract][Full Text] [Related]
2. The antilipolytic action of bis(alpha-furancarboxylato)oxovanadium(IV) in adipocytes.
Gao L; Niu Y; Liu W; Xie M; Liu X; Chen Z; Li L
Clin Chim Acta; 2008 Feb; 388(1-2):89-94. PubMed ID: 17991430
[TBL] [Abstract][Full Text] [Related]
3. Bis(alpha-furancarboxylato)oxovanadium(IV) prevents and improves dexamethasone-induced insulin resistance in 3T3-L1 adipocytes.
Zuo YQ; Liu WP; Niu YF; Tian CF; Xie MJ; Chen XZ; Li L
J Pharm Pharmacol; 2008 Oct; 60(10):1335-40. PubMed ID: 18812026
[TBL] [Abstract][Full Text] [Related]
4. Orally active and long-term acting insulin-mimetic vanadyl complex:bis(picolinato)oxovanadium (IV).
Sakurai H; Fujii K; Watanabe H; Tamura H
Biochem Biophys Res Commun; 1995 Sep; 214(3):1095-101. PubMed ID: 7575515
[TBL] [Abstract][Full Text] [Related]
5. Novel vanadyl complexes with quinoxaline N(1),N(4)-dioxide derivatives as potent in vitro insulin-mimetic compounds.
Noblía P; Vieites M; Torre MH; Costa-Filho AJ; Cerecetto H; González M; Lavaggi ML; Adachi Y; Sakurai H; Gambino D
J Inorg Biochem; 2006 Feb; 100(2):281-7. PubMed ID: 16386797
[TBL] [Abstract][Full Text] [Related]
6. Effects of bis(alpha-furancarboxylato)oxovanadium(IV) on non-diabetic and streptozotocin-diabetic rats.
Gao LH; Liu WP; Wang BL; Li L; Xie MJ; Li YR; Chen ZH; Chen XZ
Clin Chim Acta; 2006 Jun; 368(1-2):173-8. PubMed ID: 16487949
[TBL] [Abstract][Full Text] [Related]
7. Bis(allixinato)oxovanadium(IV) complex is a potent antidiabetic agent: studies on structure-activity relationship for a series of hydroxypyrone-vanadium complexes.
Adachi Y; Yoshida J; Kodera Y; Katoh A; Takada J; Sakurai H
J Med Chem; 2006 Jun; 49(11):3251-6. PubMed ID: 16722643
[TBL] [Abstract][Full Text] [Related]
8. Effects of bis(alpha-furancarboxylato)oxovanadium(IV) on glucose metabolism in fat-fed/streptozotocin-diabetic rats.
Niu Y; Liu W; Tian C; Xie M; Gao L; Chen Z; Chen X; Li L
Eur J Pharmacol; 2007 Oct; 572(2-3):213-9. PubMed ID: 17651728
[TBL] [Abstract][Full Text] [Related]
9. A new orally active antidiabetic vanadyl complex--bis(alpha-furancarboxylato)oxovanadium(IV).
Xie M; Gao L; Li L; Liu W; Yan S
J Inorg Biochem; 2005 Feb; 99(2):546-51. PubMed ID: 15621288
[TBL] [Abstract][Full Text] [Related]
10. Syntheses of vanadyl and zinc(II) complexes of 1-hydroxy-4,5,6-substituted 2(1H)-pyrimidinones and their insulin-mimetic activities.
Yamaguchi M; Wakasugi K; Saito R; Adachi Y; Yoshikawa Y; Sakurai H; Katoh A
J Inorg Biochem; 2006 Feb; 100(2):260-9. PubMed ID: 16387366
[TBL] [Abstract][Full Text] [Related]
11. Insulin-mimetic vanadyl(IV) complexes as evaluated by both glucose-uptake and inhibition of free fatty acids (FFA)-release in isolated rat adipocytes.
Adachi Y; Sakurai H
Chem Pharm Bull (Tokyo); 2004 Apr; 52(4):428-33. PubMed ID: 15056957
[TBL] [Abstract][Full Text] [Related]
12. Glucose-dependent insulin modulation of oscillatory lipolysis in perifused rat adipocytes.
Getty-Kaushik L; Richard AM; Corkey BE
Obes Res; 2005 Dec; 13(12):2058-65. PubMed ID: 16421338
[TBL] [Abstract][Full Text] [Related]
13. Effects of decavanadate and insulin enhancing vanadium compounds on glucose uptake in isolated rat adipocytes.
Pereira MJ; Carvalho E; Eriksson JW; Crans DC; Aureliano M
J Inorg Biochem; 2009 Dec; 103(12):1687-92. PubMed ID: 19850351
[TBL] [Abstract][Full Text] [Related]
14. In vivo metabolic effects of naringenin in the ethanol consuming rat and the effect of naringenin on adipocytes in vitro.
Szkudelska K; Nogowski L; Nowicka E; Szkudelski T
J Anim Physiol Anim Nutr (Berl); 2007 Apr; 91(3-4):91-9. PubMed ID: 17355338
[TBL] [Abstract][Full Text] [Related]
15. Effects of metformin and vanadium on leptin secretion from cultured rat adipocytes.
Mueller WM; Stanhope KL; Gregoire F; Evans JL; Havel PJ
Obes Res; 2000 Oct; 8(7):530-9. PubMed ID: 11068959
[TBL] [Abstract][Full Text] [Related]
16. Transferrin and iron induce insulin resistance of glucose transport in adipocytes.
Green A; Basile R; Rumberger JM
Metabolism; 2006 Aug; 55(8):1042-5. PubMed ID: 16839839
[TBL] [Abstract][Full Text] [Related]
17. Preparation and characterization of vanadyl complexes with bidentate maltol-type ligands; in vivo comparisons of anti-diabetic therapeutic potential.
Thompson KH; Liboiron BD; Sun Y; Bellman KD; Setyawati IA; Patrick BO; Karunaratne V; Rawji G; Wheeler J; Sutton K; Bhanot S; Cassidy C; McNeill JH; Yuen VG; Orvig C
J Biol Inorg Chem; 2003 Jan; 8(1-2):66-74. PubMed ID: 12459900
[TBL] [Abstract][Full Text] [Related]
18. Lack of the effect of mycotoxins-aflatoxin B1 and ochratoxin A on some functions of rat adipocytes.
Szkudelska K; Drzymała H; Szkudelski T; Bukowska K; Nogowski L
Toxicol In Vitro; 2005 Sep; 19(6):771-7. PubMed ID: 15963681
[TBL] [Abstract][Full Text] [Related]
19. Insulin mimetic effect of tungsten compounds on isolated rat adipocytes.
Topic A; Milenkovic M; Uskokovic-Markovic S; Vucicevic D
Biol Trace Elem Res; 2010 Jun; 134(3):296-306. PubMed ID: 19644657
[TBL] [Abstract][Full Text] [Related]
20. Possible mode of action for insulinomimetic activity of vanadyl(IV) compounds in adipocytes.
Kawabe K; Yoshikawa Y; Adachi Y; Sakurai H
Life Sci; 2006 May; 78(24):2860-6. PubMed ID: 16337244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]